Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|November 18, 2018
Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patientsVassiliki Kotoula, Sotirios Lakis, Ioannis Tikas, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 26, 2014
Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC)Vassiliki Kotoula, Mattheos Bobos, Maria Vassilakopoulou, et al.
Plos One|August 8, 2014
Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17Vassiliki Kotoula, Mattheos Bobos, Zoi Alexopoulou, et al.
Plos One|December 7, 2018
Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancerGenovefa Polychronidou, Vassiliki Kotoula, Kyriaki Manousou, et al.
BMC Clinical Pathology|July 3, 2014
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studiesTriantafyllia Koletsa, Flora Stavridi, Mattheos Bobos, et al.
Plos One|March 19, 2014
Differential expression of the insulin-like growth factor receptor among early breast cancer subtypesGiannis Mountzios, Dimitra Aivazi, Ioannis Kostopoulos, et al.
Anticancer Research|April 30, 2016
Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast CancerSotirios Lakis, Stefanos Dimoudis, Vassiliki Kotoula, et al.
Histology and Histopathology|March 26, 2015
Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) studyHelen P Kourea, Vassiliki Kotoula, Angelos Koutras, et al.
ESMO Open|November 2, 2019
Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)George Zarkavelis, Vassiliki Kotoula, Georgia-Angeliki Kolliou, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2015
PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patientsAnna Koumarianou, Georgia Karayannopoulou, Georgia Gourgioti, et al.
Pageof 5